Becker's Healthcare December 15, 2022
Jakob Emerson

CMS issued a proposed rule Dec. 14 to continue its efforts to overhaul prior authorization and marketing practices around Medicare Advantage and Part D plans, along with adding health equity measures to star ratings and boosting behavioral health network adequacy requirements.

The proposed rule would also implement a key prescription drug affordability provision of the Inflation Reduction Act.

“From streamlining prior authorization to cracking down on misleading marketing, we are committed to ensuring that everyone can have peace of mind and get the health care they need.” HHS Secretary Xavier Becerra said in a news release.

Comments on the proposal are due by Feb. 13. Read the full proposal here.

Prior authorization

The proposed rule would require an approved prior...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Equity/SDOH, Govt Agencies, Healthcare System, Insurance, Medicare Advantage, Mental Health, Provider
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
MedPAC Members Vote to Recommend Pay Hikes for Physicians and Hospitals
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.
HHS: Ozempic, Wegovy will be part of Medicare Part D drug price negotiations this year
CMS says record 24.2 million enrolled in Marketplace coverage for 2025

Share This Article